Vitamin D and Menopause

Menopause — the permanent cessation of menstrual cycles, average age 51 in the US — creates a hormonal shift that accelerates bone loss and changes vitamin D's role. What vitamin D does and doesn't do around menopause is often misunderstood.

Post-menopausal bone loss

Oestrogen withdrawal causes rapid bone resorption in the first 5–7 years after menopause — women lose roughly 2% of BMD per year in the trabecular spine. Vitamin D alone doesn't prevent this loss, but vitamin D adequacy is a necessary condition for calcium absorption; deficiency accelerates the loss. Anti-resorptive therapy (bisphosphonates, denosumab) and hormone therapy work more effectively when vitamin D is replete. See our osteoporosis page.

Muscle and falls

Post-menopausal women have accelerated sarcopenia, and vitamin D deficiency causes proximal myopathy. Trials of 800–1,000 IU/day + calcium in older women have shown reduced falls (Bischoff-Ferrari 2009 meta-analysis) — a preventable cause of fractures. The falls-prevention effect is one of the more consistent vitamin D trial findings.

What vitamin D doesn't do at menopause

Cardiovascular

Post-menopausal women have accelerated cardiovascular risk. The VITAL trial showed 2,000 IU/day for 5 years did not reduce major cardiovascular events in the general population, and post-hoc analyses in women did not reveal a differential benefit. Correcting deficiency remains reasonable for the general effects; do not expect cardioprotection from adding vitamin D on top of already-sufficient status.

Practical dosing at menopause

  1. Test 25(OH)D at menopause onset and every 1–2 years.
  2. Target ≥ 30 ng/mL, some clinicians aim 40–50 with osteoporosis therapy.
  3. Standard dosing 1,000–2,000 IU/day cholecalciferol.
  4. Ensure adequate calcium (1,200 mg/day total, food-preferred over supplements).
  5. DEXA scan at 65 (earlier if fracture, family history, chronic steroid, hypogonadism).
  6. Weight-bearing and resistance exercise is at least as important as any supplement.
Sponsored
Not medical advice. Post-menopausal bleeding is not normal — get it evaluated. Vaginal atrophy responds well to prescription therapy.

Related tools & guides

Advertisement